Read + Share
Huang X, Lin D, Lin S, Luo S, et al. Cost-effectiveness and Value-based Pricing of Trastuzumab Deruxtecan in
Metastatic Breast Cancer With Low HER2 Expression. Clin Breast Cancer 2023 Mar 31:S1526-8209(23)00082.
PMID: 37085377
|
 |
|
Huang X, Lin D, Lin S, Luo S, et al. Cost-effectiveness and Value-based Pricing of Trastuzumab Deruxtecan in
Metastatic Breast Cancer With Low HER2 Expression. Clin Breast Cancer 2023 Mar 31:S1526-8209(23)00082.
PMID: 37085377
|
|
|
|